OrganOx Ltd: OrganOx receives FDA approval for its liver normothermic machine perfusion system
OXFORD, England, Dec. 20, 2021 /PRNewswire/ -- OrganOx, a world leader in normothermic machine perfusion (NMP), today announced that the U.S. Food and Drug Administration (FDA) has granted premarket
Craig Marshall Stuart Knechtle Prnewswire Organox National Principal Investigator Drug Administration Executive Director
Source: finanznachrichten.de